Skip to main navigation Skip to search Skip to main content

Severe hyponatraemia associated with desmopressin nasal spray to treat clozapine-induced nocturnal enuresis

  • Shanthi Sarma
  • , Warren Ward
  • , Justin O'Brien
  • , Aaron DJ Frost
  • , Janice Iwaniak

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Desmopressin nasal spray has been recognized in the literature as a successful treatment for nocturnal enuresis in patients on clozapine [1–5]. No serious adverse reactions have been previously reported in this population. This paper reports a case of severe hyponatraemia in a 47-year-old man with schizophrenia who was commenced on desmopressin nasal spray to treat clozapineinduced nocturnal enuresis. To our knowledge, this is the first such case report.
Original languageEnglish
Pages (from-to)949-949
Number of pages1
JournalAustralian and New Zealand Journal of Psychiatry
Volume39
Issue number10
DOIs
Publication statusPublished - Oct 2005
Externally publishedYes

Fingerprint

Dive into the research topics of 'Severe hyponatraemia associated with desmopressin nasal spray to treat clozapine-induced nocturnal enuresis'. Together they form a unique fingerprint.

Cite this